ATE208198T1 - Verwendung von aminopurinen antiviralen mitteln zur behandlung und prophylaxe der latenten herpes-virus infektionen - Google Patents

Verwendung von aminopurinen antiviralen mitteln zur behandlung und prophylaxe der latenten herpes-virus infektionen

Info

Publication number
ATE208198T1
ATE208198T1 AT95941044T AT95941044T ATE208198T1 AT E208198 T1 ATE208198 T1 AT E208198T1 AT 95941044 T AT95941044 T AT 95941044T AT 95941044 T AT95941044 T AT 95941044T AT E208198 T1 ATE208198 T1 AT E208198T1
Authority
AT
Austria
Prior art keywords
aminopurines
prophylaxis
treatment
herpes virus
antiviral agents
Prior art date
Application number
AT95941044T
Other languages
English (en)
Inventor
Hugh John Field
Alana Maureen Thackray
Teresa Helen Bacon
David Sutton
Hodge Richard Anthony Vere
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE208198(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425012.3A external-priority patent/GB9425012D0/en
Priority claimed from GBGB9506663.5A external-priority patent/GB9506663D0/en
Priority claimed from GBGB9517308.4A external-priority patent/GB9517308D0/en
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Application granted granted Critical
Publication of ATE208198T1 publication Critical patent/ATE208198T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95941044T 1994-12-12 1995-11-23 Verwendung von aminopurinen antiviralen mitteln zur behandlung und prophylaxe der latenten herpes-virus infektionen ATE208198T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9425012.3A GB9425012D0 (en) 1994-12-12 1994-12-12 Pharmaceuticals
GBGB9506663.5A GB9506663D0 (en) 1995-03-31 1995-03-31 Pharmaceuticals
GBGB9517308.4A GB9517308D0 (en) 1995-08-24 1995-08-24 Pharmaceuticals
US08/522,790 US5840763A (en) 1994-12-12 1995-09-01 Treatment of a latent infection of herpes viruses
PCT/EP1995/004692 WO1996018396A1 (en) 1994-12-12 1995-11-23 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections

Publications (1)

Publication Number Publication Date
ATE208198T1 true ATE208198T1 (de) 2001-11-15

Family

ID=27451235

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941044T ATE208198T1 (de) 1994-12-12 1995-11-23 Verwendung von aminopurinen antiviralen mitteln zur behandlung und prophylaxe der latenten herpes-virus infektionen

Country Status (24)

Country Link
US (2) US5840763A (de)
EP (1) EP0799039B1 (de)
JP (1) JP2008088189A (de)
CN (1) CN1098687C (de)
AP (1) AP669A (de)
AT (1) ATE208198T1 (de)
AU (1) AU699627B2 (de)
BG (1) BG63815B1 (de)
BR (1) BR9509986A (de)
CA (1) CA2207503C (de)
CY (1) CY2339B1 (de)
CZ (1) CZ291545B6 (de)
DE (1) DE69523776T2 (de)
DK (1) DK0799039T3 (de)
ES (1) ES2166834T3 (de)
HK (1) HK1003259A1 (de)
HU (1) HU222835B1 (de)
NO (1) NO313862B1 (de)
NZ (1) NZ297424A (de)
PT (1) PT799039E (de)
RO (1) RO120042B1 (de)
SI (1) SI0799039T1 (de)
SK (1) SK282983B6 (de)
WO (1) WO1996018396A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US6047209A (en) * 1999-04-02 2000-04-04 Denny; Jeffrey Paul Method and apparatus for maintenance of pierced orifices
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
MX2007012104A (es) * 2005-03-30 2008-03-11 Novartis Ag Penclovir o famciclovir para el tratamiento de herpes genital recurrente con una aplicacion de un dia.
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
EP3753563A1 (de) * 2019-06-20 2020-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Guanosinanalog gegen herpesvirus zur hemmung der basalen autophagie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses

Also Published As

Publication number Publication date
BR9509986A (pt) 1997-11-25
SK75197A3 (en) 1997-11-05
CZ179997A3 (en) 1997-09-17
NO313862B1 (no) 2002-12-16
BG101608A (en) 1998-02-27
AP9701001A0 (en) 1997-07-31
NO972688D0 (no) 1997-06-11
SK282983B6 (sk) 2003-01-09
JP2008088189A (ja) 2008-04-17
EP0799039A1 (de) 1997-10-08
ES2166834T3 (es) 2002-05-01
CN1098687C (zh) 2003-01-15
HUT77437A (hu) 1998-04-28
DK0799039T3 (da) 2002-01-28
DE69523776D1 (de) 2001-12-13
PT799039E (pt) 2002-04-29
CZ291545B6 (cs) 2003-04-16
HU222835B1 (hu) 2003-11-28
WO1996018396A1 (en) 1996-06-20
CY2339B1 (en) 2004-02-06
EP0799039B1 (de) 2001-11-07
CA2207503A1 (en) 1996-06-20
AP669A (en) 1998-09-04
BG63815B1 (bg) 2003-02-28
US5840763A (en) 1998-11-24
RO120042B1 (ro) 2005-08-30
AU699627B2 (en) 1998-12-10
MX9704336A (es) 1997-09-30
NO972688L (no) 1997-08-07
CN1175212A (zh) 1998-03-04
NZ297424A (en) 2000-07-28
DE69523776T2 (de) 2002-08-01
AU4257896A (en) 1996-07-03
CA2207503C (en) 2006-07-18
US5916893A (en) 1999-06-29
SI0799039T1 (en) 2002-06-30
HK1003259A1 (en) 1998-10-23

Similar Documents

Publication Publication Date Title
DE69737144D1 (de) Antimikrobielle behandlung von herpes simplex viren und anderer infektioser erkrankungen
ATE201138T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
KR100344712B1 (ko) 알러지성및염증성질환의치료에유용한화합물
DE69117117D1 (de) Reinigungszusammensetzung zur Vorbeugung und Milderung von Hautreizungen
DE69520296D1 (de) Oberflächenbehandlungsmittel und Oberflächenbehandlung von Halbleiter
BR9709238A (pt) Uso de Il-12 e alfa-interferon para o tratamento de doenças infecciosas
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
ATE363904T1 (de) Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs
FI944549A (fi) Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet
DE69312853D1 (de) Behandlung von Gummiartikeln
DE69316203D1 (de) Elektrochemische behandlung von oberflächen
ATE259811T1 (de) Hemisulfat eines carbocyclischen nucleosides und seine verwendung zur behandlung von viralen infektionen
NO940810D0 (no) Behandling av virusinfeksjoner
ATE208198T1 (de) Verwendung von aminopurinen antiviralen mitteln zur behandlung und prophylaxe der latenten herpes-virus infektionen
DE69028993T2 (de) Verwendung von kaffein bei der behandlung von herpes-simplex-virusinfektionen
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
ATE151291T1 (de) Penciclovir und famciclovir und verwandte guaninderivate zur behandlung von hiv-1- infektionen
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
DE69418931D1 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
DE69302250D1 (de) Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia
DE69117566T2 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
LTIP472A (en) Composition for the treatment of infection and disease caused by hepatit b virus